市场调查报告书
商品编码
1518350
癌症资讯系统市场:依产品、应用和最终用户划分 - 2030 年全球预测Oncology Information Systems Market By Offering (Software Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) - Global Forecast to 2030 |
癌症资讯系统市场预计到 2030 年将达到 44.5 亿美元,2023 年至 2030 年复合年增长率为 7.4%。
经过广泛的二次和初步研究以及对市场情景的详细分析,本报告对关键行业驱动因素、限制因素和市场驱动因素/课题进行了分析。
该市场的成长是由癌症盛行率不断上升、癌症治疗数位化程度不断提高、降低癌症治疗成本的需求不断增加、电子健康记录(EHR) 的采用不断增加所推动的,这是由患者需求的不断增长所推动的资讯和数据管理。
然而,癌症资讯系统的高成本以及对资料安全和隐私的担忧正在限制该市场的成长。此外,精准医学融入癌症治疗及其在新兴国家日益增长的潜力预计将为该市场的参与者提供重大的成长机会。
然而,采用和实施癌症资讯系统的障碍以及使用癌症资讯系统的培训和教育的额外要求是限制市场成长的主要课题。
(註:报告中将包含5家主要公司的SWOT分析。)
Oncology Information Systems Market Size, Share, Forecast, & Trends Analysis by Offering (Software {Patient Information, Treatment Planning}, Services), Application (Surgical, Radiology Oncology), End User (Hospital, Cancer Care) - Global Forecast to 2030
The oncology information systems market is projected to reach $4.45 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, the growing need to reduce oncology care costs, the increasing adoption of Electronic Health Records (EHR), and the growing demand for streamlined patient information and data management.
However, the high cost of oncology information systems and data security and privacy concerns are restraining the growth of this market. In addition, the integration of precision medicine into cancer treatment and its growing potential in emerging countries are expected to generate significant growth opportunities for the players in this market.
However, barriers to the adoption and implementation of oncology information systems and additional requirements for training and education for using oncology information systems are major challenges limiting the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).
Based on offering the oncology information systems market is segmented into software and services. In 2023, the software segment is expected to account for the larger share of the oncology information systems market. The large share of this segment is attributed to the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.
Based on application, the oncology information systems market is segmented into medical oncology, radiation oncology, and surgical oncology. In 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.
Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement oncology information systems, and increased number of cancer patients relying on hospitals for treatment.
An in-depth analysis of the geographical scenario in the oncology information systems market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the oncology information systems market. North America's major market share is primarily attributed to the robust healthcare infrastructure, high healthcare expenditure, large patient population, high adoption of precision medicine, and the presence of key market players in the region.
Oncology Information Systems Market Assessment-by Offering
Oncology Information Systems Market Assessment-by Application
Oncology Information Systems Market Assessment-by End User
Note: Other end users primarily include research institutes and government institutions.
Oncology Information Systems Market Assessment-by Geography
(Note: SWOT Analysis Of The Top 5 Players Will Be Provided In The Report)